1. Home
  2. MFI vs CNSP Comparison

MFI vs CNSP Comparison

Compare MFI & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MFI
  • CNSP
  • Stock Information
  • Founded
  • MFI 2002
  • CNSP 2017
  • Country
  • MFI Hong Kong
  • CNSP United States
  • Employees
  • MFI N/A
  • CNSP N/A
  • Industry
  • MFI
  • CNSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • MFI
  • CNSP Health Care
  • Exchange
  • MFI NYSE
  • CNSP Nasdaq
  • Market Cap
  • MFI 9.9M
  • CNSP 6.5M
  • IPO Year
  • MFI 2024
  • CNSP 2019
  • Fundamental
  • Price
  • MFI $0.65
  • CNSP $0.14
  • Analyst Decision
  • MFI
  • CNSP Strong Buy
  • Analyst Count
  • MFI 0
  • CNSP 1
  • Target Price
  • MFI N/A
  • CNSP $0.50
  • AVG Volume (30 Days)
  • MFI 285.8K
  • CNSP 13.4M
  • Earning Date
  • MFI 02-24-2025
  • CNSP 03-31-2025
  • Dividend Yield
  • MFI N/A
  • CNSP N/A
  • EPS Growth
  • MFI N/A
  • CNSP N/A
  • EPS
  • MFI N/A
  • CNSP N/A
  • Revenue
  • MFI $3,877,747.00
  • CNSP N/A
  • Revenue This Year
  • MFI N/A
  • CNSP N/A
  • Revenue Next Year
  • MFI N/A
  • CNSP N/A
  • P/E Ratio
  • MFI N/A
  • CNSP N/A
  • Revenue Growth
  • MFI N/A
  • CNSP N/A
  • 52 Week Low
  • MFI $0.51
  • CNSP $0.08
  • 52 Week High
  • MFI $14.49
  • CNSP $23.90
  • Technical
  • Relative Strength Index (RSI)
  • MFI N/A
  • CNSP 70.62
  • Support Level
  • MFI N/A
  • CNSP $0.09
  • Resistance Level
  • MFI N/A
  • CNSP $0.12
  • Average True Range (ATR)
  • MFI 0.00
  • CNSP 0.02
  • MACD
  • MFI 0.00
  • CNSP 0.00
  • Stochastic Oscillator
  • MFI 0.00
  • CNSP 52.83

About MFI MF INTERNATIONAL LIMITED

mF International Ltd is a holding company and all of its operations are carried out by Operating Subsidiaries in Hong Kong. It is a financial trading solution provider principally engaged in the development and provision of financial trading solutions. It has experience in providing real-time mission-critical forex, bullion/commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via internet or platform as software as a service. The company has provided a wide range of top-notch services, including mF4 Trading Platform, Bridge and Plugins, CRM System, ECN System, Liquidity Solutions, Cross-platform Broker Plus Solution, Social Trading Applications and others.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: